Atlas Trials

Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

Clinical trial NCT03453632 · UNKNOWN

Trial details

NCT number
NCT03453632
Sponsor
University Hospital, Toulouse
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Epidermolysis Bullosa Simplex
Start date
2018-06-14
Primary completion
2023-09-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.